NHS

NICE recommends funding for psoriasis and type 1 diabetes drugs
NICE recommends funding for psoriasis and type 1 diabetes drugs
Pharmaforum
NICE
UK
NHS
AbbVie
Skyrizi
AstraZeneca
Farxiga
Flag link:
After years of delays, NICE backs Celgene’s Revlimid in first-line MM
After years of delays, NICE backs Celgene’s Revlimid in first-line MM
Pharmaforum
Celgene
Revlimid
Multiple Myeloma
NICE
NHS
England
Flag link:
Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff
Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff
Fierce Pharma
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
NHS
UK
Orkambi
Flag link:
Novartis’ CAR-T cancer drug available on NHS to young people
Novartis’ CAR-T cancer drug available on NHS to young people
Pharmaforum
Novartis
CAR-T
NHS
refractory B-cell acute lymphoblastic leukemia
Kymriah
Flag link:
While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal
While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal
Endpoints
Brexit
UK
pharma industry
NHS
ABPI
Flag link:
NHS, Gilead reach agreement for Yescarta
NHS, Gilead reach agreement for Yescarta
BioCentury
Yescarta
Gilead Sciences
UK
NHS
CAR-T
Flag link:
NICE rejects Novartis’ CAR-T in adult lymphoma
NICE rejects Novartis’ CAR-T in adult lymphoma
Pharmaforum
NICE
UK
Novartis
CAR-T
Kymriah
NHS
diffuse large B-cell lymphoma
Flag link:
NHS Ordered To Cover Gilead’s HIV Drug In Court Ruling
NHS Ordered To Cover Gilead’s HIV Drug In Court Ruling
Xtalks
NHS
Gilead Sciences
HIV
Truvada
UK
Flag link:
Pfizer's leukemia drug approved by UK cost watchdog after previous rejection
Pfizer's leukemia drug approved by UK cost watchdog after previous rejection
BioPharma Dive
Pfizer
UK
Bosulif
NHS
leukemia
Flag link:
Pfizer to cover NHS docs' script-switching costs in latest Lyrica-protecting move
Pfizer to cover NHS docs' script-switching costs in latest Lyrica-protecting move
Fierce Pharma
Pfizer
NHS
England
Lyrica
physicians
Flag link:
Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Bloomberg
Amgen
Prolia
UK
NHS
Flag link: